CION Ameerpet
Risk & Causes · Reviewed by CION Oncologists · NABH Accredited
Birth Control Pills and Cervical Cancer Risk
Long-term use of the combined pill is genuinely associated with a higher risk of cervical cancer — but the association is smaller, more conditional and more reversible than the headlines suggest. It depends on how many years you have used it, it only operates where a high-risk HPV infection is present, and it fades after you stop. Meanwhile the same pill substantially lowers the risk of ovarian and endometrial cancer. This page sets out what the evidence actually says so you can weigh it properly with your doctor — not so you stop your contraception after reading a website.
- HPV is still the cause — the pill is a co-factor, and without the virus there is nothing to act on
- Duration is what matters — the association grows with years of continuous use, not with ever having taken it
- It reverses — risk declines after stopping and approaches never-user levels roughly a decade later
- Screening settles it — Pap smear and HPV test in one 45-minute visit, woman doctor on request
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Do Birth Control Pills Cause Cervical Cancer?
No — not in the sense of being a cause. Cervical cancer requires persistent infection with high-risk HPV, and no hormone will produce it in a woman who does not have that infection. What the evidence shows is narrower and more specific: among women who do carry high-risk HPV, many years of continuous combined oral contraceptive use is associated with a greater chance that the infection progresses to precancer and then to cancer. That makes the pill a co-factor, in the same category as tobacco rather than in the same category as the virus.
The most-cited evidence comes from a pooled international reanalysis of dozens of epidemiological studies, brought together by the International Collaboration of Epidemiological Studies of Cervical Cancer. Two findings from it shape everything on this page. First, the association rises steadily with duration of current use, with roughly a doubling of relative risk in women who have used it for five years or more. Second — and this is the part rarely quoted — the excess declines steadily after stopping, and by around ten years after cessation it is no longer detectably different from women who never used it.
- Ever having taken the pill is not the issue. A few years of use in your twenties is not what these studies are describing.
- Current, long-duration use is what carries the association — and it is measured in years, not months.
- It is reversible, which is unusual among cancer risk factors and genuinely reassuring.
- Relative risk is not absolute risk. Doubling a small individual risk still leaves a small individual risk.
- The same pill lowers ovarian and endometrial cancer risk, an effect that lasts for years after stopping. Any honest account has to include that.
If you take one thing from this page, make it this: the co-factor only matters if the virus is there, and a single test tells you whether it is. That is why the useful response to this worry is a screening appointment, not a decision to stop contraception. The wider picture of what raises and lowers risk sits on what actually causes cervical cancer.
Did You Know? The International Agency for Research on Cancer evaluates combined oral contraception as carcinogenic to humans with respect to the cervix, the breast and the liver — and, in the very same evaluation, as protective against cancer of the endometrium and the ovary. It is one of the clearest examples in oncology of an exposure whose effects run in both directions, which is precisely why the decision belongs in a conversation with your doctor rather than in a headline. Source: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100A (Pharmaceuticals).
Reading the Evidence Properly
Eight things that are true at the same time. Holding all of them together is what turns a frightening statistic into a usable one.
Finding 1
Risk Rises With Years of Use
The pooled analyses show a clear duration-response pattern. Short-term use sits close to never-use; the association becomes clearly measurable at around five years of continuous current use and increases with longer durations.
Finding 2
And Falls Again After Stopping
The excess risk declines year on year after cessation, approaching the level of never-users roughly a decade later. Very few cancer risk factors behave this reversibly, and it is the single most reassuring feature of the data.
Finding 3
Relative Is Not Absolute
A doubled relative risk sounds alarming and often is not. If a woman's individual chance is small to begin with, doubling it leaves a number that is still small — and that is before screening, which removes most of it again.
Mechanism
Hormones and Viral Genes
The leading explanation is that oestrogen and progesterone influence the expression of HPV genes within infected cervical cells, favouring persistence and progression. It is a proposed mechanism supported by laboratory work, not a settled certainty.
Mechanism
Changes at the Cervical Surface
Long-term hormonal use is associated with cervical ectropion, where the more delicate glandular cells sit on the outer cervix. That tissue is more exposed, more fragile, and may bleed on contact — usually a benign finding in itself.
Caveat
Confounding Is Hard to Remove
Women on the pill may differ from women not on it in HPV exposure, condom use and screening habits. The large analyses adjust for what they can, but researchers themselves treat some residual confounding as likely.
Balance
Real Protection Elsewhere
Oral contraception substantially reduces the long-term risk of ovarian and endometrial cancer, and that protection persists for many years after stopping. It also treats heavy bleeding, painful periods and other conditions.
The point
None of It Matters Without HPV
Every mechanism above acts on an existing high-risk HPV infection. If you are HPV-negative, the pill has nothing to work with — which is why the useful next step is a test, not a decision.
Hormonal contraception sits in a wider set of modifiable factors, most of which matter less than screening does. See lifestyle and cervical cancer risk for how they compare, and smoking and cervical cancer for the co-factor with the strongest evidence of all.
What This Should — and Should Not — Change
The most common harm this topic causes is not cancer. It is women stopping effective contraception abruptly after reading something frightening, and facing an unintended pregnancy. Here is the more sensible version.
Do not stop without a plan
An unintended pregnancy carries its own substantial risks, and the pill's protective effects on the ovary and endometrium are real. If after discussion you decide to change method, change to something else rather than to nothing. That conversation belongs with the doctor who prescribes your contraception, not with an oncologist and certainly not with a website.
Do get screened, and keep getting screened
This is the response that actually reduces risk. Screening detects the precancerous change that the co-factor is supposed to be accelerating, at a stage where an outpatient procedure removes it entirely. A woman on the pill for fifteen years who screens on schedule is in a far better position than a woman who has never used hormones and never been tested.
Do treat bleeding as a symptom, not a side effect
Breakthrough bleeding in the first few months on a new method is expected. Bleeding after sex, bleeding that starts after years of stable use, or bleeding that does not settle should be examined rather than attributed to the pill. That is a rule about symptoms, and it does not change because you are on contraception.
Do deal with the co-factors you can
If you smoke and take the combined pill, stopping smoking addresses the strongest co-factor and also removes a well-known cardiovascular concern with combined contraception, particularly over the age of 35. That is one decision solving two problems.
A useful way to think about it: the pill can slightly raise the odds that a persistent HPV infection progresses. Screening finds that progression while it is still precancer, and precancer is treated in a single outpatient visit. The co-factor operates over a decade; the test that intercepts it takes minutes. If you have used hormonal contraception for years and have never had a cervical screening test, that gap is the real issue on this page.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Stop Guessing. Get the One Test That Answers It.
Pap smear and HPV test from a single sample, in one appointment, at any of CION's 7 NABH-accredited Hyderabad locations. Woman doctor available on request.
How to Weigh It Up — Five Questions Worth Answering
The evidence does not produce a single instruction that fits every woman. It produces a set of questions, and the answers are different at 24 than at 44. These are the ones an oncologist would actually ask you.
1. Do you carry high-risk HPV?
This is the first question because it determines whether the rest matter at all. A high-risk HPV test on cervical cells answers it directly. If it is negative, there is currently nothing for the hormonal co-factor to act on; if it is positive, you now have a reason to be more attentive to your screening interval rather than to panic.
2. How many years, and are you still taking it?
The association is strongest in current, long-duration users and declines after stopping. Two years of use is a very different conversation from fifteen continuous years, and fifteen years that ended a decade ago is different again.
3. What is the pill doing for you?
Contraception is the obvious answer, but many women also take it for heavy or painful periods, endometriosis, polycystic ovary syndrome or acne, and it lowers ovarian and endometrial cancer risk in the background. A benefit you actually need weighs against a small, reversible, conditional risk.
4. What would you switch to?
If you and your doctor decide to change, the alternatives include non-hormonal options such as the copper intrauterine device, barrier methods, and hormonal methods that deliver hormone differently. Some studies have reported a lower cervical cancer risk among intrauterine device users, though that finding is not settled and should not be the sole reason to choose one. Barrier methods also reduce HPV transmission, though they do not eliminate it because HPV spreads through skin contact beyond the area a condom covers.
5. When were you last screened?
Whatever you decide about method, this is the question that changes your actual outcome. Screening is what converts a statistical worry into a known result, and it is the step that would have prevented most of the cervical cancers we treat. If a cancer is ever found, the treatment pathway is explained on our cervical cancer treatment in Hyderabad page — but the great majority of women reading this will never need it.
Contraceptive Method and the Cervix — What Is Known
A summary of the evidence, not a prescription. Choosing a method involves effectiveness, side effects, your medical history and your preferences — cervical cancer risk is one input among several, and usually not the deciding one.
| Method | What the evidence suggests for the cervix | What to do |
|---|---|---|
| Combined pill, under 5 years | Association close to that of never-users | Screen on the normal schedule; no change needed |
| Combined pill, 5 years or more, current | The group in which the association is clearest | Discuss duration at your next review; do not miss a screening test |
| Combined pill, stopped years ago | Excess declines after stopping, approaching never-user levels | Nothing special — keep to the routine screening interval |
| Progestogen-only methods | Evidence is more limited and less consistent than for the combined pill | Screen as normal; decide the method on other grounds |
| Copper intrauterine device | Some studies report a lower cervical cancer risk; not settled | A reasonable non-hormonal option, chosen with your gynaecologist |
| Condoms | Reduce HPV transmission but do not eliminate it | Useful for HPV and other infections; still screen on schedule |
| Any method, plus smoking | Tobacco is the stronger co-factor, and adds cardiovascular risk with the combined pill | Address the tobacco first; raise it at your contraception review |
| Any method, with new abnormal bleeding | Assessed as a symptom, whatever contraception you use | Get examined rather than waiting for the next screening interval |
Decisions about which contraceptive to use are made with the doctor who prescribes it. What an oncology clinic contributes is the screening test, the interpretation of the result, and treatment of anything abnormal that is found.
Did You Know? The reversal is the headline nobody prints. In the pooled international analyses of oral contraception and cervical cancer, the raised risk seen in long-term current users declines steadily after stopping and is no longer detectably different from never-users about ten years after cessation. Very few cancer associations behave this way — and it means a decision you made at 22 is not a sentence you carry at 52. Source: International Collaboration of Epidemiological Studies of Cervical Cancer, pooled reanalysis of individual data from epidemiological studies.
Why Women in Hyderabad Get Screened at CION
A worry about the pill deserves a real answer — the test, the result, and someone who will explain what it means.
Pap smear and HPV test in one visit
Woman doctor available on request
45-minute detailed consultation
Your result explained, not just reported
On-site colposcopy and biopsy
17 oncologists across the group
7 NABH-accredited Hyderabad locations
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
A Small, Reversible Risk Deserves a Simple Response
Not stopping your contraception in a panic. Just a screening test, a clear result, and a schedule you can keep.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Birth Control and Cervical Cancer — Frequently Asked Questions
Should I stop taking the pill because of cervical cancer risk?
Not on the basis of a website, and not abruptly. The association applies mainly to long-term current use, it is modest in absolute terms, it reverses after stopping, and it only operates where a high-risk HPV infection is present. Against it sit real benefits: reliable contraception, control of heavy or painful periods, and a substantial reduction in ovarian and endometrial cancer risk. If you want to change method, discuss it with the doctor who prescribes your contraception and switch to another effective option rather than to nothing. Meanwhile, book a screening test — that is the step that genuinely lowers your risk.
How long does the extra risk last after I stop the pill?
It declines steadily rather than disappearing overnight. The pooled international analyses show the excess risk in former users falling year on year after stopping, and by roughly ten years after cessation it is no longer detectably different from women who never used oral contraception. This reversibility is one of the more reassuring aspects of the evidence and is rarely mentioned alongside the headline figure. It also means a long period of use in your twenties is not something you carry indefinitely — provided you keep up with cervical screening in the meantime.
If my HPV test is negative, does the pill still matter for my cervix?
Every proposed mechanism by which hormonal contraception affects the cervix acts on an existing high-risk HPV infection, whether by influencing the expression of viral genes in infected cells or by changing the cervical surface. Without that infection there is nothing for it to act on, so a negative high-risk HPV test is genuinely reassuring. It is a snapshot rather than a permanent guarantee, since a new infection can be acquired later. Keep to the screening interval your doctor recommends, and treat any new abnormal bleeding as something to be examined rather than assumed.
Is a copper IUD safer for the cervix than the pill?
A copper intrauterine device delivers no hormones, so the mechanism described on this page does not apply to it, and some studies have reported a lower cervical cancer risk among intrauterine device users. That finding is not settled, and it is not a strong enough basis on its own for changing method. Choose contraception on effectiveness, side effects, your medical history and your own preferences, with the doctor who prescribes it. Whatever you choose, the screening schedule stays the same — no contraceptive method removes the need for a Pap smear and HPV test.
I have taken the pill for over ten years. What should I actually do now?
Book a cervical screening test, ideally a Pap smear together with a high-risk HPV test, and find out where you stand rather than estimating from a statistic. Mention the duration of use to the doctor, along with whether you smoke, so your screening interval can be set sensibly. If the result is normal and HPV-negative, you have your answer and a date to come back. If HPV is detected, you are in exactly the situation screening is designed for, and the follow-up plan begins straight away. Then, separately, review the contraception itself with your prescribing doctor.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It is not a diagnosis, it is not contraceptive advice for any individual, and it cannot replace an examination or a screening test. Do not start or stop prescribed contraception on the basis of a website — discuss it with the doctor who prescribes it.